A Phase 1/2, Placebo-Controlled, Randomized Study to Eva

Project: Research project

Project Details

Description

A Phase 1/2, Placebo-Controlled, Randomized Study to Evaluate the Safety, Immune Response and Clinical Activity of HS-410 in Patients with Non-Muscle Invasive Bladder Cancer Who Have Undergone Transurethral Resection of Bladder Tumor (TURBT)
StatusFinished
Effective start/end date5/1/154/30/17

Funding

  • HEAT BIOLOGICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.